10.12SEK0.00%Mkt Cap: 83.01M $P/E: —1d ago
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap83.01M $
Enterprise Value89.11M $
Revenue (TTM)518.43K $
Gross Profit291.07K $
Net Income (TTM)-1.71M $
Revenue/Share0.0061 USD
Last Price10.12 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees139
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-55.75
EV/Revenue171.89
P/S174.67
P/B23.79
EPS (TTM)-2.09
EPS (Forward)—
52W Range
10.026% of range11.70
52W High11.70 SEK
52W Low10.02 SEK
Profitability
Gross Margin85.82%
Oper. Margin-262.56%
EBITDA Margin0.00%
Profit Margin-504.74%
ROE-41.84%
ROA-33.16%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.69M $
CapEx (TTM)108.76K $
FCF Margin-205.15%
FCF Yield-1.28%
Net Debt-1.36M $
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.15
Current Ratio4.01
Quick Ratio3.79
Book Value/Sh0.4640 SEK
Cash/Share0.2400 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.85.75M
Float24.60M
Insiders23.28%
Institutions38.27%
Technical
SMA 509.455 (+7.0%)
SMA 2008.993 (+12.5%)
Beta0.78
S&P 52W Chg20.80%
Avg Vol (30d)9.28K
Avg Vol (10d)13.17K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—